Dr. Robert K. Stuart, MD
- Medicare services, 2021
- 234
- Part D claims, 2021
- 399
- Publications
- 46
- Clinical trials
- 10
- Industry payments
- $18,723
- Practice address
- 171 Ashley Ave, Charleston, SC 29425
- Practice phone
- Call (843) 792-1414
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
MUSC University Hospital
Charleston, South Carolina
Find Dr. Stuart's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Robert K. Stuart is a hematologist and oncologist in Charleston, South Carolina
Dr. Stuart practices at MUSC University Hospital in Charleston, South Carolina.
Dr. Stuart's NPI, 1467560409, was assigned on August 29, 2006. Dr. Stuart holds South Carolina license 12458.
- NPI
- 1467560409NPI Registry (opens in a new tab)
- NPI enumeration date
- August 29, 2006
- NPI status
- Active
- Practice phone
- (843) 792-1414
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Robert K. Stuart practices at MUSC University Hospital in Charleston, South Carolina
Dr. Stuart's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.
- MUSC University Hospital171 Ashley Ave, Charleston, SC 29425 · Charleston CountyPhone(843) 792-1414
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Robert K. Stuart is affiliated with 2 sites of care and 3 medical groups
Dr. Stuart's primary practice is MUSC University Hospital in Charleston, South Carolina. The medical group on file is Mercy Clinic Oklahoma Communities. Dmand AI also links Dr. Stuart to 2 more medical groups and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Robert K. Stuart's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stuart practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| MUSC University Hospital | Available with a free account |
| +1 more site and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Robert K. Stuart is one of 157 hematologists and oncologists in South Carolina
Hematology and oncology is Dr. Stuart's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Stuart is licensed in South Carolina.
Specialties and state licenses
- Hematology and oncology, South CarolinaPrimary
Hematologists and oncologists near Dr. Stuart
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Robert K. Stuart billed Medicare for 234 services in 2021
CMS data shows 234 Medicare services from Dr. Stuart across 3 procedure codes in 2021, all of them office visits. Medicare paid $15,038 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Stuart's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 6472021: 23464%
- Surgery
- 2020: 182021: 0100%
Dr. Stuart compared with the South Carolina median for hematologists and oncologists, 2021
- Dr. Stuart
- South Carolina median
- Medicare services
- 234vs 1,53485% below
- Part D claims
- 399vs 68642% below
Medians across 160 hematologists and oncologists in South Carolina with Dmand AI profiles that report each measure.
Dr. Stuart's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Stuart?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Stuart and other hematologists and oncologists in South Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Robert K. Stuart's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Stuart's median patient age at 68, with 57% women.
Dr. Stuart's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women57%
- Men43%
Source: Dmand AI Patient Panel Data
Dr. Robert K. Stuart wrote 399 Medicare Part D claims in 2021
In 2021, Dr. Stuart wrote 399 Medicare Part D claims. They cover 14 drugs, with $3,805,852 in total drug cost. In 2020, CMS named 673 claims across 22 drugs.
Dr. Stuart's most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2021
- 2020
- 2021
- Claims for drugs CMS names
- 2020: 6732021: 39941%
Drugs named by CMS: 14 in 2021, 22 in 2020.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Robert K. Stuart has 46 publications on record
Dmand AI links 46 papers to Dr. Stuart, published from 2010 to 2020. 2011 was the busiest year, with 6. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Leukemia, Myeloid, Acute and Antineoplastic Agents. Dr. Stuart has published most often in Blood Adv. Dr. Stuart's most frequent co-authors are Luciano J. Costa, Yubin Kang, MD and Jeffrey E. Lancet, MD.
Dr. Stuart's papers by year, 2011 to 2020
Topics Dr. Stuart writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Leukemia, Myeloid, Acute
- Antineoplastic Agents
- Multiple Myeloma
- Cytarabine
- Daunorubicin
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cell Transplantation
Dr. Stuart's most frequent co-authors
Recent publications by Dr. Stuart
See who Dr. Stuart researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Stuart works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Robert K. Stuart has worked on 10 clinical trials
Dmand AI links Dr. Stuart to 10 clinical trials, 2 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Anemia, Aplastic. National Cancer Institute (NCI) sponsors the most, 2. Open Payments lists research payments to Dr. Stuart that name 1 trial.
Clinical trials with Dr. Stuart by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Stuart's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
- Anemia, Aplastic
- Lymphoma, Follicular
- Multiple Myeloma
Investigators on the most trials with Dr. Stuart
- Stephen Anthony Strickland, MD3 shared trials
- Mhd Monzr Al Malki, MD2 shared trials
- Julie D. Asch, MD2 shared trials
Recent clinical trials with Dr. Stuart
A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy (opens in a new tab)
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies (opens in a new tab)
A Randomized Multicenter Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Robert K. Stuart received $18,723 in industry payments from 2016 to 2024
CMS Open Payments shows 46 general payments to Dr. Stuart from 15 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 65% of the total. Amgen Inc. paid the most, $7,301. It also lists 6 research payments totaling $7,514 from 2019 to 2024, naming 1 clinical trial.
General payments to Dr. Stuart by program year, 2016 to 2024
General payments to Dr. Stuart by kind, 2016 to 2024
- Consulting fees$12,15065%
- Travel and lodging$4,31723%
- Food and beverage$1,6089%
- Compensation for serving as faculty or as a speaker for a medical education program$5063%
- Education$1421%
Companies that paid Dr. Stuart the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Robert K. Stuart's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Robert K. Stuart
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Robert K. Stuart's NPI number?
Dr. Robert K. Stuart's NPI number is 1467560409. It was assigned on August 29, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Robert K. Stuart?
Dr. Robert K. Stuart is a hematologist and oncologist in Charleston, South Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Robert K. Stuart practice?
Dr. Stuart practices at 171 Ashley Ave, Charleston, SC 29425. Dr. Stuart's primary practice is MUSC University Hospital in Charleston, South Carolina. Dmand AI also links Dr. Stuart to 2 medical groups and 1 group practice or clinic.
What is Dr. Robert K. Stuart's office phone number?
The practice phone on file for Dr. Stuart is (843) 792-1414.
What is Dr. Robert K. Stuart's medical license number?
Dr. Stuart holds South Carolina license 12458.
What medical group is Dr. Robert K. Stuart part of?
Dr. Stuart is linked to Mercy Clinic Oklahoma Communities. Dmand AI links Dr. Stuart to 2 more medical groups.
Does Dr. Robert K. Stuart accept Medicare?
Yes. CMS data shows Dr. Stuart billed Medicare for 234 services in 2021.
What services does Dr. Robert K. Stuart bill to Medicare?
In 2021, Dr. Stuart's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, established patient (99213).
What drugs does Dr. Robert K. Stuart prescribe most?
In 2021 Medicare Part D data, Dr. Stuart's most prescribed drugs by claims were Imbruvica, Imatinib Mesylate and Acyclovir.
Has Dr. Robert K. Stuart received payments from drug or device companies?
CMS Open Payments shows $18,723 in general payments to Dr. Stuart from 15 companies from 2016 to 2024. The largest total came from Amgen Inc.
Show 3 more questionsShow fewer questions
How long has Dr. Robert K. Stuart been practicing?
Dr. Stuart's NPI was assigned in 2006.
Does Dr. Robert K. Stuart do research?
Dmand AI links 46 publications to Dr. Stuart, published from 2010 to 2020. Dr. Stuart has worked on 10 clinical trials.
Who does Dr. Robert K. Stuart publish with?
Dr. Stuart's most frequent co-authors are Luciano J. Costa (7 shared papers), Yubin Kang, MD (7 shared papers) and Jeffrey E. Lancet, MD (6 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in South Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card